2024-03-29T12:28:33Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_8FE5A2441A77
2024-03-23T02:41:15Z
serval:BIB_8FE5A2441A77
Anti-MAG antibodies in 202 patients: clinicopathological and therapeutic features.
10.1136/jnnp-2017-316715
000430495800013
29070644
Svahn
J.
author
Petiot
P.
author
Antoine
J.C.
author
Vial
C.
author
Delmont
E.
author
Viala
K.
author
Steck
A.J.
author
Magot
A.
author
Cauquil
C.
author
Zarea
A.
author
Echaniz-Laguna
A.
author
Iancu Ferfoglia
R.
author
Gueguen
A.
author
Magy
L.
author
Léger
J.M.
author
Kuntzer
T.
author
Ferraud
K.
author
Lacour
A.
author
Camdessanché
J.P.
author
Francophone anti-MAG cohort Group
contributor
article
2018-05
Journal of neurology, neurosurgery, and psychiatry
1468-330X
0022-3050
journal
89
5
499-505
Adult
Aged
Aged, 80 and over
Autoantibodies/blood
Drug Therapy, Combination
Female
Humans
Immunologic Factors/therapeutic use
Immunosuppressive Agents/therapeutic use
Male
Middle Aged
Myelin-Associated Glycoprotein/immunology
Paraproteinemias/blood
Paraproteinemias/drug therapy
Paraproteinemias/immunology
Polyneuropathies/blood
Polyneuropathies/drug therapy
Polyneuropathies/immunology
Prospective Studies
Retrospective Studies
Rituximab/therapeutic use
eng
60_published
peer-reviewed
Publication types: Clinical Trial ; Journal Article ; Multicenter Study
Publication Status: ppublish